The Clinicopathologic Evaluation of Eosinophilic Cholecystitis: A Retrospective Observational Study in a Tertiary Care Center

  • Senay Erdogan-Durmus Department of Pathology, Istanbul Basaksehir Cam and Sakura City Hospital, İstanbul, Turkey
  • Hilal Balta Department of Pathology, Fırat University Medical Facult, Elazığ, Turkey
  • Sevilay Ozmen Department of Pathology, Atatürk University Medical Faculty, Erzurum, Turkey
  • Ilknur Calik Department of Pathology, Fırat University Medical Facult, Elazığ, Turkey
  • Yusuf Can Department of Pathology, Erzurum Region Training and Research Hospital, Erzurum
  • Ali Kurt Department of Pathology, Erzurum Region Training and Research Hospital, Erzurum
Keywords: cholecystitis, eosinophilia, cholelithiasis, histopathology

Abstract

Background: Eosinophilic cholecystitis (EC) is a rare form of cholecystitis that is diagnosed histopathologically. The aim of this study to evaluate the patient demographic features, laboratory findings and histopathologic characteristics of EC. The aim of this study to evaluate the patient demographic features, laboratory findings and histopathologic characteristics of EC. Design and setting: Retrospective observational study conducted in Erzurum, Turkey. Methods: Between June 2014 and June 2017 3,178 cholecystectomy specimens were reviewed retrospectively. Nineteen EC cases were included to the study. Parameters such as sex, age, clinical information, laboratory findings were obtained from information system of hospital. And the data of EC group were compared with a control group of 50 non-specific chronic cholecystitis patients (CC). Result: Out of 3,178 cholecystectomy specimens, 19 cases were diagnosed as EC (0.59%). Patients’ age ranged from 22-84 years and female to male ratio was 1.7:1. The average eosinophil count was 139.7 U/L in EC group. 11.7% of EC group had high level for eosinophils. In the EC group there were statistical significances between high eosinophil percentages and aspartate transaminase (AST), alkaline phosphatase (ALP) values (P<0.05, P<0.05). The EC group eosinophil levels were slightly higher than CC. Histopathologically, dense, severe infiltrates composed of eosinophils were seen. Conclusion: EC is a rare entity that can only diagnosed by histopathology.  There were certain high levels in liver function tests and eosinophils in correlation with non-specific cholecystitis. Although the presentation may be similar to non-specific cholecystitis, if a postoperative histopathological diagnosis of EC is made, then the patient must be investigated thoroughly to rule out other associated disease conditions. 

References

del-Moral-Martínez M, Barrientos-Delgado A, Crespo-Lora V, Cervilla-Sáez-de-Tejada ME, Salmerón-Escobar J. Eosinophilic cholecystitis: an infrequent cause of acute cholecystitis. Rev Esp Enferm Dig. 2015;107:45-7. P

Choudhury M, Pujani M, Katiyar Y, Jyotsna PL, Rautela A. Idiopathic eosinophilic cholecystitis with cholelithiasis: a report of two cases. Turk Patoloji Derg. 2014;30:142-4.

Jesserun J, Pambuccian S. Infectious and inflammatory disorders of the gallblader and extrahepatic biliary tract. In: Odze RD, Goldblum JR, editors. Surgical Pathology of the GI Tract, Liver, Biliary Tract and Pancreas. 3rd ed. China: Elsevier Saunders; 2015. 995-1021.

Yeom SS, Kim HH, Kim JC, et al. Peripheral eosinophilia – is it a predictable factor associated with eosinophilic cholecystitis?. Korean J Hepatobiliary Pancreat Surg 2012;16:65-9.

Russell CO, Dowling JP, Marshall RD. Acute eosinophilic cholecystitis in association with hepatic echinococcosis. Gastroenterology. 1979;77:758-60.

Hepburn A, Coady A, Livingstone J, Pandit N. Eosinophilic cholecystitis as a possible late manifestation of the eosinophilia-myalgia syndrome. Clin Rheumatol. 2000;19:470-2.

Adusumilli PS, Lee B, Parekh K, Farrelly PA. Acalculous eosinophilic cholecystitis from herbal medicine: a review of adverse effects of herbal medicine in surgical patients. Surgery. 2002;131:352-6.

Cerdán Santacruz C, Martín Antona E, Martín García-Almenta E, Díez Valladares L, Torres García AJ. Eosinophilic cholecystitis after elective cholecystectomy for gallbladder stones. Cir Esp. 2013;91:460-1.

Saks K, Amjadi D, D’Souza SL. Eosinophilic cholecystitis and enteritis associated with ampullary stenosis. Clin Gastroenterol Hepatol. 2017;15:A23-A24.

Shakov R, Simoni G, Villacin A, Baddoura W. Eosinophilic cholecystitis, with a review of the literature. Ann Clin Lab Sci. 2007;37:182-5.

Singh DK, Shankar R, Gondal R, Malhotra V, Mishra P. Idiopathic eosinophilic cholecystitis with cholelithiasis: A case report and review of literature. Internet Journal of Surgery. 2008;16:2.

Jarema M, Bieńkowski P, Heitzman J, Parnowski T, Rybakowski J. Paliperidone palmitate: effectiveness, safety, and the use for treatment of schizophrenia. Psychiatr Pol. 2017;26;51(1):7-21.

Gordon JR, Swystun VA, Li F, Zhang X, Davis BE, Hull P, Cockcroft DW. Regular salbutamol use increases CXCL8 responses in asthma: relationship to the eosinophil response. Eur Respir J. 2003;22(1):118-26.

Tajima K, Katagiri T. Deposits of eosinophil granule proteins in eosinophilic cholecystitis and eosinophilic colitis associated with hypereosinophilic syndrome. Dig Dis Sci. 1996;41:282-8.

Kim YH. Eosinophilic cholecystitis in association with clonorchis sinensis infestation in the common bile duct. Clin Radiol. 1999;54:552-4.

Khan S, Hassan MJ, Jairajpuri ZS, Jetley S, Husain M. Clinicopathological Study of Eosinophilic Cholecystitis: Five Year Single Institution Experience. J Clin Diagn Res. 2017;11:EC20-EC23.

Kumar V, Verma R, Dawan S, Choudhary M, Verma S, Dhaka JP. Incidence of Eosinophilic Cholecystitis in Northwestern Region of Rajasthan: A Study in Consecutive 867 Cholecystectomies. Int J Sci Stud. 2016;4:150-3.

Mallat F, Hmida W, Mestiri S, et al. Eosinophilic Cystitis with Eosinophilic Cholecystitis: A Rare Association. Case Rep Urol. 2013;2013:146020.

Published
2021-06-30
Section
Original Article